Keros Therapeutics, Inc. - COM (KROS)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
34.9M
Holdings value Q3 2024
$2.03B
Value change Q3 2024
+$197M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
161
Number of buys Q3 2024
91
Number of sells Q3 2024
-60
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 34.9M $2.03B +$197M $58.07 162
2024 Q2 31.4M $1.44B -$2.07M $45.70 148
2024 Q1 31.3M $2.08B +$375M $66.20 143
2023 Q4 25.7M $1.02B +$111M $39.76 117
2023 Q3 22.8M $727M +$7.88M $31.88 103
2023 Q2 22.4M $900M +$13.2M $40.18 119
2023 Q1 22M $937M +$94.6M $42.70 127
2022 Q4 19.7M $948M +$89.7M $48.02 119
2022 Q3 18.1M $680M +$30M $37.62 105
2022 Q2 17.4M $480M +$10.3M $27.63 100
2022 Q1 16.4M $893M +$13.7M $54.38 100
2021 Q4 16.1M $944M +$68.4M $58.51 95
2021 Q3 13.7M $543M -$15.8M $39.56 85
2021 Q2 14.1M $599M -$43.6M $42.47 78
2021 Q1 14.4M $887M -$123M $61.55 82
2020 Q4 16M $1.13B +$301M $70.54 80
2020 Q3 11.8M $455M +$33.8M $38.57 49
2020 Q2 10.9M $410M +$410M $37.51 51